Are decentralised trials here to stay? Who knows…. CONTEXT: This is an opinion piece from Veradigm® asking whether decentralised trials will live on beyond the pandemic and as they have Continue Reading
French researchers first exposure to decentralised trials CONTEXT: Discussion article on one French company’s first experience with the concept of decentralised clinical trials and how they went about solving the Continue Reading
Goldman Sachs invest $230M in CRO on the back of the decentralised trials craze CONTEXT: Goldman Sachs joins the decentralised trial Gold rush to invest in the contract clinical research Continue Reading
Decentralised Trials here to stay, but maybe not as many as we think. CONTEXT: A new report from Science 37 (a provider of Decentralised Clinical Trial (DCT) Software) based on Continue Reading
CONTEXT: Commercial announcement from PCM trials of the opening of a London office to better serve their decentralised trial offering in Europe. IMPACT: Low READ TIME: 1 min Quality Level Continue Reading
CONTEXT: Commercial announcement – Syneos expands its decentralised trial offering IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 3 ” TRIALS & FILINGS Novavax COVID-19 Vax Continue Reading
CONTEXT: Opinion piece on decentralised trials. Interesting timing ahead of the DIA making the topic a major platform for this year’s get together. IMPACT: Low READ TIME: 2 mins Continue Reading
CONTEXT: A teaser article for the DIA 2021 where discussions are expected around decentralised trials and accelerated approval pathways. The DIA has always a great place for the industry to Continue Reading
CONTEXT: Commercial announcement of CVS Health joining the push for decentralised clinical trials with the formation of a new business unit. This pharmacy chain is just the latest in a Continue Reading
CONTEXT: Increased backing for the post-COVID era decentralised clinical trials. Can’t help thinking that this feels like a dot com bubble that will burst when the first major safety concerns Continue Reading
